233 related articles for article (PubMed ID: 29377379)
21. Levels of oxidative stress biomarkers and bone resorption regulators in apical periodontitis lesions infected by Epstein-Barr virus.
Jakovljevic A; Andric M; Nikolic N; Coric V; Krezovic S; Carkic J; Knezevic A; Beljic-Ivanovic K; Pljesa-Ercegovac M; Miletic M; Soldatovic I; Radosavljevic T; Jovanovic T; Simic T; Ivanovic V; Milasin J
Int Endod J; 2018 Jun; 51(6):593-604. PubMed ID: 29315650
[TBL] [Abstract][Full Text] [Related]
22. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Li L; Sapkota M; Kim SW; Soh Y
Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730
[TBL] [Abstract][Full Text] [Related]
23. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
24. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
[TBL] [Abstract][Full Text] [Related]
25. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
26. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
27. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Kassem A; Lindholm C; Lerner UH
PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis.
Yang L; Chang N; Liu X; Han Z; Zhu T; Li C; Yang L; Li L
Am J Pathol; 2012 Jul; 181(1):85-97. PubMed ID: 22609227
[TBL] [Abstract][Full Text] [Related]
29. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
30. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
[TBL] [Abstract][Full Text] [Related]
31. Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.
Molstad DHH; Mattson AM; Begun DL; Westendorf JJ; Bradley EW
J Biol Chem; 2020 Dec; 295(51):17713-17723. PubMed ID: 33454009
[TBL] [Abstract][Full Text] [Related]
32. Different correlation of sphingosine-1-phosphate receptor 1 with receptor activator of nuclear factor kappa B ligand and regulatory T cells in rat periapical lesions.
Xiao L; Zhu L; Yang S; Lei D; Xiao Y; Peng B
J Endod; 2015 Apr; 41(4):479-86. PubMed ID: 25492490
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway.
Yang J; Yang L; Tian L; Ji X; Yang L; Li L
Cell Physiol Biochem; 2018; 49(5):1677-1693. PubMed ID: 30231248
[TBL] [Abstract][Full Text] [Related]
34. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
35. BMAL1 regulates balance of osteogenic-osteoclastic function of bone marrow mesenchymal stem cells in type 2 diabetes mellitus through the NF-κB pathway.
Li X; Liu N; Gu B; Hu W; Li Y; Guo B; Zhang D
Mol Biol Rep; 2018 Dec; 45(6):1691-1704. PubMed ID: 30259246
[TBL] [Abstract][Full Text] [Related]
36. LncRNA XIST facilitates S1P-mediated osteoclast differentiation via interacting with FUS.
Zhang DW; Wang HG; Zhang KB; Guo YQ; Yang LJ; Lv H
J Bone Miner Metab; 2022 Mar; 40(2):240-250. PubMed ID: 35066669
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate/S1P receptors signaling modulates cell migration in human bone marrow-derived mesenchymal stem cells.
Kong Y; Wang H; Lin T; Wang S
Mediators Inflamm; 2014; 2014():565369. PubMed ID: 25147438
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL.
Xing R; Zhang Y; Li C; Sun L; Yang L; Zhao J; Liu X
Int J Mol Med; 2016 Oct; 38(4):1125-34. PubMed ID: 27599586
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5-lipoxygenase gene disruption on inflammation, osteoclastogenesis and bone resorption in polymicrobial apical periodontitis.
Paula-Silva FWG; Arnez MFM; Petean IBF; Almeida-Junior LA; da Silva RAB; da Silva LAB; Faccioli LH
Arch Oral Biol; 2020 Apr; 112():104670. PubMed ID: 32058859
[TBL] [Abstract][Full Text] [Related]
40. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS
Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
